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Background: To estimate the extents of dosing variability in prescriptions of acetaminophen to children among
pediatricians, family physicians and otolaryngologists.
Methods: The acetaminophen prescriptions in the systematic sampling datasets from the National Health Insurance
Research Database in Taiwan were analyzed. The distribution of dosages was measured and expressed in terms of
coefficient of variation (CV). The analyses were stratified by patient’s age, prescriber’s specialty and preparation form.
Results: From 13,868 prescribed items of acetaminophen in 2009, liquids accounted only for 11.1% (n = 1544). More
than half (56.9%) of liquids were prescribed by pediatricians. The median dose (83.3 mg, n = 1683) of
acetaminophen prescriptions in infants is around half of that in preschool children (166.7 mg, n = 3921), one-third
in children (250.0 mg, n = 4926) and one-sixth in adolescents (500.0 mg, n = 3338). In infants, the prescriptions by
pediatricians had the highest CV (86.7%), followed by family physicians (82.3%) and otolaryngologists (70.3%). The
patterns were similar in preschool children and children, but the difference of CV among specialties narrowed
down with the patient’s age.
Conclusions: In acetaminophen prescriptions to children, pediatricians had a wider variability of dosages and a
higher ratio of liquid preparations than family physicians and otolaryngologists. Further investigations can be
undertaken to estimate the accuracy of dosing variability as an indicator of prescribing quality. Besides,
child-suitable drug preparations should be promoted to ensure patient safety.
Keywords: Drug dosage calculations, Drug prescriptions, National health programs, Physician’s practice patternsBackground
Children are not the exact miniatures of adults. The dos-
ages of most medicines prescribed to children should be
adjusted according to their ages and weights because
children are not completely mature in development and
the pharmacokinetics of a drug in them is hardly calcul-
able [1]. For example, the half-life of acetaminophen,
one of the most common antipyretics, is much slower in
neonates than in adults [2]. Therefore, children are more
vulnerable to dosing errors [3]. It has been also reported* Correspondence: ycchouvgh@gmail.com
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reproduction in any medium, provided the orthat not all physicians prescribed for children according
to package inserts or guidelines [4-6]. Furthermore, the
degree of prescribing discordance differed among spe-
cialties [7,8]. Most studies of cross-specialty prescription
comparisons measured merely the appropriateness of in-
dications [9], the choice of drugs [10,11], and the num-
ber of distinct drug items [12]. In some studies dealing
with dosing problems, questionnaires [13], quizzes or
chart reviews were usually adopted in research methods.
To establish an indicator of prescribing quality in dosing
within large-scale prescription databases, a more effi-
cient approach is thus necessary.
In this study, we proposed a new method to estimate the
extents of dosing variability in prescriptions to childrentd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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were from a large nationwide health insurance claims data-
base in Taiwan, the concept and procedures of our study




The National Health Insurance (NHI) in Taiwan started
in 1995 and covered 23,025,773 beneficiaries [14] (about
99% of 23,119,772 inhabitants [15]) at the end of 2009.
Since 1999, the Bureau of National Health Insurance
(BNHI) has released the claims data in electronic form
to the National Health Research Institutes for research
use under the project of National Health Insurance
Research Database (NHIRD). Some dozen kinds of
extracted datasets are available on application.
From the NHIRD, we obtained the ambulatory part of
systematic sampling datasets in 2009. This kind of
datasets was randomly sampled in a ratio of 1/500 from
the entire datasets of the NHI in the year. It was com-
posed of claims of 576,416 visits and 2,765,389 prescrip-
tions in 2009. The data of each visit included the date of
the consultation, the consulted physician’s specialty, and
the patient’s age, sex and birthday. The data of each pre-
scribed drug item included the drug identification num-
ber, dosage, frequency, and total amount. On the web
site of the BNHI we could look up the ingredient, dosage
form and strength of a drug according to its identifica-
tion number. An interface for searching drug items
according to the ingredient was also available.
Subjects
This study has been approved by the institutional review
board of Taipei Veterans General Hospital, Taipei, Taiwan.
This study is the cross-sectional, observational data-
base analysis. We limited our analysis to prescriptions
given to children not older than 18 years who were then
grouped into infant (younger than 2 years), preschool
child (2 to 5 years), child (6 to 11 years), and adolescent
(12 to 17 years). To simplify the analysis, we further
limited the analysis to drug items containing acetamino-
phen which was the most frequently prescribed ingredi-
ent as antipyretics and analgesics in children [16]. It was
generally recommended that in patients younger than
13 years the dosage of acetaminophen should be ad-
justed according to body weight [17].
To calculate the dosage of acetaminophen in each pre-
scription, we at first identified 288 drug items containing
acetaminophen from the web site of the BNHI. The
exact single dosage in unit of milligram was computed
by multiplying the strength with the prescribed quantity,
in either single-ingredient or compound preparations. In
the analysis, the various drug forms were grouped intoliquid (22 items, including syrup and elixir), tablet (200
items, including sugar-coated tablet and chewable tab-
let), capsule (62 items), and others (4 items, including
oral granules and suppository). According to the reim-
bursement regulations of the NHI, liquid forms of drugs
could only be prescribed to children under 13 years or
on special situations. Furthermore, we analyzed only the
regular prescriptions. The prescriptions as statim, pro re
nata and ut dictum as well as outliers with dosages
greater or less than 1.5 interquartile ranges were ex-
cluded from analysis.
To make a cross-specialty comparison of dosing vari-
ability, we chose only three major specialties: pediatrics,
family medicine and otolaryngology. A recent study
about child care within the NHI in Taiwan revealed that
these three specialties covered 93.3% of ambulatory visits
by children younger than 7 years [18]. Because people in
Taiwan could freely choose physicians and healthcare
settings without referral and the copayment was rela-
tively low within the NHI, otolaryngologists became the
second largest specialty in providing ambulatory health
care, especially in treating diseases of the respiratory sys-
tem that accounted for one third of ambulatory visits
[19]. In Taiwan, the share of otolaryngology in ambula-
tory care could reach 9.5% in general population [19]
and as high as 20.7% in children [18].
Although the NHI claims were lacking in the data of
body weight, we supposed that the patients in each of
three specialties have similar distributions of body
weights. On this assumption, we would compare the dis-
tributions of acetaminophen dosages prescribed by phy-
sicians in three specialties. Our hypothesis was that
pediatricians should be more likely to prescribe on the
basis of a patient’s body weight. The dosing variability by
pediatricians should be more marked than that by family
physicians or otolaryngologists. The extent of difference
in dosing variability between family physicians/otolaryn-
gologists and pediatricians might serve as a quality indi-
cator of prescribing.
Statistical analysis
The database management software of Microsoft SQL
2008 (Microsoft Corp., Redmond, WA, USA) was used
for data linkage and processing. At first, descriptive sta-
tistics were presented. Besides the mean and standard
deviation (SD), we used the coefficient of variation (CV)
to represent the dosing variability of acetaminophen pre-
scriptions. The CV, defined as the ratio of the standard
deviation to the mean, was thought to be more accurate
than standard deviations to compare the variability [20]
and usually applied to represent laboratory values, e.g.
red blood cell distribution width in complete blood
count. The results were stratified by child’s age group,
prescriber’s specialty and dosage form of acetaminophen
Table 1 Features of patients receiving prescriptions (N = 13868) of acetaminophen
Infant Preschool child Child Adolescent
(<2 y/o) (2–5 y/o) (6–11 y/o) (12–17 y/o)
No. of patients 1683 3921 4926 3338
Male (%) 763 (45.3) 1838 (46.9) 2345 (47.6) 1578 (47.3)
Female (%) 919 (54.6) 2083 (53.1) 2580 (52.4) 1760 (52.7)
Missing (%) 1 (0.1) 1 (0.0)
Patient’s age, mean ± SD, y 1.2 ± 0.5 4.0 ± 1.1 8.8 ± 1.7 14.8 ± 1.6
Prescriber’s specialty
Pediatrics (%) 962 (57.2) 1752 (44.7) 1833 (37.2) 806 (24.1)
Family medicine (%) 374 (22.2) 1007 (25.7) 1528 (31.0) 1367 (41.0)
Otolaryngology (%) 347 (20.6) 1162 (29.6) 1565 (31.7) 1165 (34.9)
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used to explore whether the single dosages of acet-
aminophen prescriptions in each age group and pre-
scriber’s specialty followed the normal distribution. The
Wilcoxon rank-sum test was used to compare the distri-
bution of acetaminophen dosages in family medicine or
otolaryngology with that in pediatrics. A value of p <
0.05 was regarded as statistically significant. Statistical
analyses were performed using the IBM SPSS statistical
package, version 19.0.
Results
From the sampling datasets of the NHIRD in 2009, we
identified 110,825 visits by children. The visits to pediatri-
cians, family physicians and otolaryngologists amounted toTable 2 Forms of acetaminophen preparations in 13868 presc
specialty
No. of prescriptions Liquida (%)
Infant
Pediatrics 962 358 (37.2)
Family medicine 374 109 (29.1)
Otolaryngology 347 73 (21.0)
Preschool child
Pediatrics 1752 378 (21.6)
Family medicine 1007 169 (16.8)
Otolaryngology 1162 143 (12.3)
Child
Pediatrics 1833 142 (7.7)
Family medicine 1528 100 (6.5)





a including syrup and elixir.
b including suppository and oral granules.73.1% (n = 80991) of all visits. Among the visits to these
three specialties, acetaminophen was prescribed in 18,965
(23.4%) visits. After elimination of 5,193 prescriptions as
statim, pro re nata, ut dictum, with outlier in dosage or ob-
vious data entry error, 13,868 prescribed items of acet-
aminophen remained for further analysis: 1,683 to infants,
3,921 to preschool children, 4,926 to children, and 3,338 to
adolescents (Table 1). Pediatricians accounted for 38.6%
(n = 5,353) of acetaminophen prescriptions, family physi-
cians for 30.8% (n = 4,276) and otolaryngologists for 30.6%
(n = 4,239). The share of pediatricians decreased with the
patient’s age: from 57.2% in infants to 24.1% in adolescents.
As to drug forms, 1,544 (11.1%) prescribed items
belonged to liquids, 12,112 (87.3%) to tablets, 205 (1.5%)
to capsules, and 7 (0.1%) to others. While liquidsriptions, stratified by patient’s group and prescriber’s
Tablet (%) Capsule (%) Othersb (%)
594 (61.7) 10 (1.0)
257 (68.7) 8 (2.1)
270 (77.8) 2 (0.6)
1352 (77.2) 22 (1.3) 2 (0.6)
797 (79.1) 41 (4.1)
1010 (86.9) 4 (0.3)
1649 (90.0) 42 (2.3) 5 (0.4)
1388 (90.8) 40 (2.6)
1458 (93.2) 35 (2.2)
806 (100.0)
1366 (100.0) 1 (0.1)
1165 (100.0)
Figure 1 Distribution of dosages in acetaminophen prescriptions in each patient’s group, stratified by prescriber’s specialty: (A) infant;
(B) preschool child; (C) child; and (D) adolescent. Box plots show the median and interquartile ranges of acetaminophen dosages. The
“whiskers” outside the box indicate the 10th and 90th percentiles; solid circles indicate the 5th and 95th percentiles.
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infants, the share decreased to 17.6% in preschool chil-
dren and 6.4% in children. Pediatricians were more likely
to prescribe liquid forms of acetaminophen than family
physicians and otolaryngologists. But the cross-specialty
disparity diminished with the patient’s age (Table 2).
About the distribution of acetaminophen dosage, the
median dose (83.3 mg) of acetaminophen prescriptions
in infants is around half of that in preschool children
(166.7 mg), one-third in children (250.0 mg) and one-
sixth in adolescents (500.0 mg) (Figure 1). In average,
otolaryngologists prescribed the highest dosage in in-
fants, preschool children and children, while family
physician prescribed a higher dosage than pediatricians
only in infants and children (Table 3). The cross-
specialty disparity of dosage disappeared in adolescents.
As to measurement of dosing variability in terms of
CV, the acetaminophen prescriptions in adolescents had
the lowest CV (2.8-3.5%). In infants, the prescriptions by
pediatricians had the highest CV (86.7%), followed by
family physicians and otolaryngologists. The patterns
were similar in preschool children and children, but the
difference of CV among specialties narrowed down withthe patient’s age (Table 3). Within the same specialty,
CV also decreased with the patient’s age.
Discussion
Our results revealed that the relative ratios of median
doses of acetaminophen among all age groups were
quite similar to those of median body weights in CDC
Growth Charts [21] and to those of recommended doses
in pharmacopeia [22]. It implied that most physicians
paid attention to the child’s body weight or age in pre-
scribing. Thus, even though the information of body
weight was not available in the claims datasets, we might
infer from the dosing variability among specialty groups
that the prescribing quality of physicians with narrower
variability needed to be further scrutinized.
On the other hand, we could neither directly prove
that the CV of dosages was suitable to serve as a meas-
urement of prescribing quality. According to the Child
Growth Standards published by the World Health
Organization [23], the variation of body weight in in-
fants is most marked and the extent of variation declines
with age. In our study, the CV in each specialty also
decreased with children’s age. Besides, children aged
Table 3 Distribution of acetaminophen dosages in 13868 prescriptions, stratified by patient’s group and prescriber’s
specialty
No. of prescriptions Median, mg Mean (SD), mg Coefficient of variation,% P valuea
Infant
Pediatrics 962 80.0 72.3 (62.7) 86.7 -
Family medicine 374 83.3 79.6 (65.5) 82.3 0.033*
Otolaryngology 347 91.7 91.0 (64.0) 70.3 <0.001*
Preschool child
Pediatrics 1752 166.7 145.8 (98.8) 67.8 -
Family medicine 1007 150.0 140.3 (90.1) 64.2 0.135
Otolaryngology 1162 166.7 162.3 (92.1) 56.7 <0.001*
Child
Pediatrics 1833 250.0 279.1 (148.2) 53.1 -
Family medicine 1528 250.0 295.1 (150.0) 50.8 0.007*
Otolaryngology 1565 277.8 305.4 (140.7) 46.1 <0.001*
Adolescent
Pediatrics 806 500.0 498.1 (13.9) 2.8 -
Family medicine 1367 500.0 498.1 (14.0) 2.8 0.747
Otolaryngology 1165 500.0 497.2 (17.2) 3.5 0.201
a Wilcoxon rank-sum test.
* statistically significant.
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of acetaminophen as adults, without regard to body
weight [17]. In our study, the CV in each specialty was
also negligibly small in adolescents (Table 3). The pat-
tern of CVs reflected their usefulness in cross-specialty
comparisons.
In our study, otolaryngologists had the narrowest dos-
ing variability in children younger than 12 years. It was
understandable that otolaryngologists with the back-
ground of surgically-oriented training might not be
familiar with pediatric prescription or accustomed to
dosing practice. The discrepancy of practice patterns
between otolaryngologists and pediatricians had been
reported, especially in treatment of acute otitis media
and tonsillitis [24,25]. A survey of otolaryngologists and
pediatricians about deficiency of cross-training in
Canada had also revealed that otolaryngologists felt a
need of medication and dosage knowledge to be taught
by pediatricians during otolaryngology residency [26].
Modification of training programs or continuing educa-
tion might be considered to resolve the cross-specialty
discrepancy.
As hypothesized in our study, the prescriptions by pe-
diatricians had indeed higher CVs of acetaminophen
dosages than those by family physicians and otolaryngol-
ogists. The cross-specialty differences of CVs decreased
with patient’s age and disappeared in adolescents. Our
study also revealed that pediatricians prescribed much
more preparations in liquid forms than family physicians
and otolaryngologists did. In Taiwan, many physicianclinics still have dispensing practice [27,28]. The formu-
laries available to family physicians and otolaryngologists
might lack preparations suitable for child use. Dose
adjustment in tablets and capsules was less easily
performed than in liquid preparations. Beside physician’s
prescribing skills, the problem of formulary might be an-
other explanatory factor of cross-specialty discrepancy in
dosing variability. Because the sample size in each sub-
group stratified by age and preparation form would
become too small, we could not ascertain the role of
preparation form in our study. However, our findings
still highlighted the need of provision of child-suitable
preparations as currently promoted by major global
health organizations [29,30].
Our study with claims data from NHIRD had some
limitations. First, the indications for acetaminophen pre-
scribing were not analyzed in our study. The claims rec-
ord of an ambulatory visit contained three diagnostic
fields. It was technically difficult to attribute acetamino-
phen to a diagnosis. Besides, acetaminophen was usually
used to alleviate symptoms rather than to cure diseases.
Second, for children aged between one and 12 years, the
body weight increased almost linearly with age. Because
of sample sizes, we adopted broader grouping of patients
instead of presenting the results with a resemblance to
growth charts. However, for children aged under one
year, especially neonates, pediatricians might be the
main health providers, potentially contributing to a
higher dosing variability of acetaminophen prescriptions
in infants treated by pediatricians. Third, from the
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aminophen was taken in a divided tablet or capsule. In
real life, splitting or grinding might lead to more dosage
deviation than physician’s prescribing did. This issue
would go beyond the scope of our study.
Conclusions
In acetaminophen prescriptions to children, pediatricians
had a wider variability of dosages and a higher ratio of
liquid preparations than family physicians and otolaryn-
gologists. Further investigations can be undertaken to esti-
mate the accuracy of dosing variability as an indicator of
prescribing quality. Besides, child-suitable drug prepara-
tions should be promoted to ensure patient safety.
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